{
    "Orphapacket": {
        "ORPHApacketId": "604680",
        "creationDate": "2024-07-01 09:48:26",
        "version": "1.3.29 / 4.1.7 [2023-08-02] (orientdb version)",
        "copyright": "Orphanet (c) 2024",
        "ORPHAcode": "604680",
        "Label": "Symptomatic form of X-linked centronuclear myopathy in female carriers",
        "PURL": "http://www.orpha.net/ORDO/Orphanet_604680",
        "DisorderType": {
            "value": "Disease",
            "PURL": "http://www.orpha.net/ORDO/Orphanet_377788"
        },
        "Synonyms": [
            {
                "Synonym": "Symptomatic form of X-linked myotubular myopathy in female carriers"
            },
            {
                "Synonym": "Symptomatic form of XLCNM in female carriers"
            },
            {
                "Synonym": "Symptomatic form of XLMTM in female carriers"
            }
        ],
        "ExternalReferences": [
            {
                "Source": "OMIM",
                "Reference": "310400",
                "DisorderMappingRelation": "NTBT (ORPHAcode is narrower than the targeted code used to represent it)"
            }
        ],
        "TextSection": {
            "TextSectionType": "Definition",
            "Contents": "A rare centronuclear myopathy characterized by a variable severity of muscle weakness which is typically asymmetric with a limb-girdle pattern. Severity can range from skeletal asymmetry to loss of ambulation. Other manifestations may include respiratory muscle weakness urinary incontinence bulbar signs (facial weakness limitation of extra-ocular movements ophthalmoparesis ptosis and dysarthria) or skeletal involvement (kyphoscoliosis scoliosis joint hyperlaxity joint contractures of the lower extremities foot deformities and hand and/or facial contractures). Many female carriers remain asymptomatic."
        },
        "Parents": [
            {
                "Parent": [
                    {
                        "ORPHAcode": "207110",
                        "Label": "Qualitative or quantitative defects of myotubularin"
                    }
                ]
            },
            {
                "Parent": [
                    {
                        "ORPHAcode": "595",
                        "Label": "Centronuclear myopathy"
                    }
                ]
            }
        ],
        "Prevalences": [
            {
                "Prevalence": {
                    "Source": "28685322[PMID]_34011573[PMID]_ORPHANET",
                    "PrevalenceType": "Cases/families",
                    "PrevalenceQualification": "Case",
                    "PrevalenceClass": "no data",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Worldwide"
                }
            },
            {
                "Prevalence": {
                    "Source": "28685322[PMID]_34011573[PMID]_ORPHANET",
                    "PrevalenceType": "Point prevalence",
                    "PrevalenceQualification": "Class only",
                    "PrevalenceClass": "<1 / 1 000 000",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Worldwide"
                }
            }
        ],
        "AverageAgeOfOnsets": [
            {
                "AverageAgeOfOnset": {
                    "value": "Childhood"
                }
            },
            {
                "AverageAgeOfOnset": {
                    "value": "Infancy"
                }
            },
            {
                "AverageAgeOfOnset": {
                    "value": "Neonatal"
                }
            }
        ]
    }
}